<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>Jahrom University of Medical Sciences</PublisherName>
				<JournalTitle>Pars Journal of Medical Sciences</JournalTitle>
				<Issn>2717-0284</Issn>
				<Volume>21</Volume>
				<Issue>3</Issue>
				<PubDate PubStatus="epublish">
					<Year>2024</Year>
					<Month>01</Month>
					<Day>21</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Study on the correlation between single nucleotide polymorphism frequency in TYK2 gene with COVID-19 disease</ArticleTitle>
<VernacularTitle>Study on the correlation between single nucleotide polymorphism frequency in TYK2 gene with COVID-19 disease</VernacularTitle>
			<FirstPage>64</FirstPage>
			<LastPage>72</LastPage>
			<ELocationID EIdType="pii">710171</ELocationID>
			
<ELocationID EIdType="doi">10.22034/pjms.2024.710171</ELocationID>
			
			<Language>FA</Language>
<AuthorList>
<Author>
					<FirstName>Hediyeh</FirstName>
					<LastName>Tamimi</LastName>
<Affiliation>Department of Genetics, Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-8637-5908</Identifier>

</Author>
<Author>
					<FirstName>Flora</FirstName>
					<LastName>Forouzesh</LastName>
<Affiliation>Department of Genetics, Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Pooneh</FirstName>
					<LastName>Rahimi</LastName>
<Affiliation>Department of Hepatitis and AIDS and Blood Transmitted Diseases, Pasteur Institute of Iran, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0001-8829-5373</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2023</Year>
					<Month>11</Month>
					<Day>29</Day>
				</PubDate>
			</History>
		<Abstract>Introduction: The diversity in outcomes of COVID-19 infection and understanding its underlying reasons have led to&lt;br /&gt;a global health challenge. Genetic features, especially variations in immune system genes, are considered as crucial factors contributing to the clinical diversity resulting from infections with viruses such as SARS-CoV-2.&lt;br /&gt;Materials and Methods: In this study, DNA was extracted from blood samples of 220 COVID-19 patients. The PCR-RFLP&lt;br /&gt;method was employed to identify single nucleotide polymorphisms in the Tyrosine Kinase 2 (TYK2) gene. After PCR amplification, the PCR products were enzymatically digested with AluI enzyme, and the resulting fragments were separated using gel electrophoresis. Phenotypes of each patient were determined by analyzing the created fragments, and for final confirmation, some samples were sent for sequencing.&lt;br /&gt;Results: The study population included 102 recovered patients with mild COVID-19 and 118 deceased patients with severe disease. The frequency of the rs11085727 polymorphism in the TYK2 gene was statistically examined in both patient groups, revealing a significantly higher frequency in the deceased group compared to the recovered group &lt;br /&gt;(p&lt; 0.05).&lt;br /&gt;Conclusion: Examining genetic factors and their variations, especially investigating single nucleotide polymorphisms in genes related to the innate immune system, can play a significant role in predicting susceptibility to COVID-19 and adopting personalized therapeutic approaches based on patients&#039; genetics. According to the results obtained in this research, the rs11085727 polymorphism in the TYK2 gene is likely associated with the severity of COVID-19.</Abstract>
			<OtherAbstract Language="FA">Introduction: The diversity in outcomes of COVID-19 infection and understanding its underlying reasons have led to&lt;br /&gt;a global health challenge. Genetic features, especially variations in immune system genes, are considered as crucial factors contributing to the clinical diversity resulting from infections with viruses such as SARS-CoV-2.&lt;br /&gt;Materials and Methods: In this study, DNA was extracted from blood samples of 220 COVID-19 patients. The PCR-RFLP&lt;br /&gt;method was employed to identify single nucleotide polymorphisms in the Tyrosine Kinase 2 (TYK2) gene. After PCR amplification, the PCR products were enzymatically digested with AluI enzyme, and the resulting fragments were separated using gel electrophoresis. Phenotypes of each patient were determined by analyzing the created fragments, and for final confirmation, some samples were sent for sequencing.&lt;br /&gt;Results: The study population included 102 recovered patients with mild COVID-19 and 118 deceased patients with severe disease. The frequency of the rs11085727 polymorphism in the TYK2 gene was statistically examined in both patient groups, revealing a significantly higher frequency in the deceased group compared to the recovered group &lt;br /&gt;(p&lt; 0.05).&lt;br /&gt;Conclusion: Examining genetic factors and their variations, especially investigating single nucleotide polymorphisms in genes related to the innate immune system, can play a significant role in predicting susceptibility to COVID-19 and adopting personalized therapeutic approaches based on patients&#039; genetics. According to the results obtained in this research, the rs11085727 polymorphism in the TYK2 gene is likely associated with the severity of COVID-19.</OtherAbstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">single nucleotide polymorphism</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Tyrosine Kinase</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">SARS CoV-2</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">COVID-19</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://jmj.jums.ac.ir/article_710171_89d8f8a646d2cd41613041511e8de64f.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
